ISRCTN62825862已完成不适用
The MISSION! Intervention Study: A Prospective Randomised Controlled Trial to Evaluate the Efficacy of Drug-Eluting Stents versus Bare-Metal Stents for the Treatment of Acute Myocardial Infarctio
eiden University Medical Centre, Department of Cardiology (Netherlands)0 个研究点目标入组 300 人开始时间: 2006年1月27日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Between 18 and 80 years of age
- •2. ECG evidence of an acute myocardial infarction
- •3. De novo native culprit lesion
- •4. Target vessel with a reference diameter between 2.25 and 3.75 mm
- •5. Target lesion length = 24 mm
- •6. Written informed consent
排除标准
- •1. Rescue PTCA
- •2. Start symptoms >9 hours before the procedure
- •3. Left main lesion with = 50% diameter stenosis
- •4. Triple vessel disease
- •5. Involvement of a major side branch
- •6. Previous PCI or CABG of the culprit vessel
- •7. Renal insufficiency
- •8. Unwilling or unable to comply with the study requirements or follow-up evaluations
- •9. Contraindication for abciximab
- •10. Extensive peripheral vascular disease
- •11. Non-cardiac illness with a life expectancy less than 12 months
研究者
相似试验
已完成
不适用
MISSION! Intervention Study.Acute myocardial infarction.NL-OMON28145eiden University Medical CenterDepartment of CardiologyAlbinusdreef 22300 RC Leiden300
进行中（未招募）
不适用
APPRECIATERheumatoid arthritisJPRN-jRCTs031210665Kawahito Yutaka55
招募中
2 期
Efficacy of Intraoperative Fluorescence Diagnosis in Meningioma surgerymeningiomaMeningiomaJPRN-jRCTs031210158Masahide Matsuda22
尚未招募
Unknown
A study to assess the role of CognitiveBotics software (Artificial Intelligence based software) in the management of Autism Spectrum Disorder.CTRI/2023/06/054257CognitiveBotics Technologies Private Limited
招募中
1 期
REIMAGINE – Real-world EvaluatIon of Mepolizumab in severe Asthma achievinG on treatment clinIcal remissioN, a prospEctive study.MedDRA version: 21.1Level: LLTClassification code: 10068462Term: Eosinophilic asthma Class: 10038738severe asthmaCTIS2023-509026-21-00Glaxosmithkline Research & Development Limited336